Infectious Diseases

ImmunoPrecise Antibodies (IPA) Demonstrates Strong Market Confidence with I

Precision BioSciences Receives Approval in Hong Kong to Expand PBGENE-HBV P

Viz.ai Integrates Avicenna.AI's Tools for ASPECTS Stroke Severity Assessmen

Syncell Announces $15 Million Series A Funding to Accelerate the Global Com

Xaira Therapeutics Announces the Appointment of Dr. Paulo Fontoura as Chief

ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Busines

IPA to Present at The Benchmark Company’s Upcoming Discovery One-on-One I

IPA to Report Financial Results and Recent Business Highlights for Second Q

Elemental Machines Launches New Product to Enhance Clean Room Alerting and

Precision BioSciences to Participate in Upcoming November Investor Conferen

AN2 Therapeutics to Participate at Upcoming Investor Conferences

Medidata and Bioforum Bolster Decade-Long Relationship to Advance Clinical

Healx announces agreement with Sanofi to seek new rare disease indications

Attivare Therapeutics Appoints David Sherris, Ph.D. as President, CEO, and

ImmunoPrecise to Host TECHDAY: Cutting-Edge AI and Biologics Innovation

Arrowhead Pharmaceuticals Launches New Disease Awareness Campaign, ‘We’

ASP Japan G.K. Certified as a Great Place To Work® for Third Consecutive Y

Medidata Launches Bundled Solutions to Support Oncology and Vaccine Trials,

Precision BioSciences to Report Third Quarter Results on November 4, 2024

PopVax Announces 1.15 Million USD in Funding from the Bill & Melinda Gates

Precision BioSciences to Host Virtual Investor Event Highlighting PBGENE-HB